Haleon PLC has completed the acquisition of an additional 33% equity interest in its China-based joint venture, Tianjin TSKF Pharmaceutical Co. Ltd, for approximately £0.5 billion. This move ...
(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback